Literature DB >> 16567718

Correlation of visual hallucinations with occipital rCBF changes by donepezil in DLB.

T Mori1, M Ikeda, R Fukuhara, P J Nestor, H Tanabe.   

Abstract

The authors explored the neural substrate of visual hallucinations in dementia with Lewy bodies (DLB) by investigating changes in regional cerebral blood flow (rCBF) and psychiatric symptoms, before and after cholinesterase inhibitor treatment. Twenty subjects with DLB were treated with donepezil for a 12-week period. Hallucinations attenuated while receiving therapy, whereas occipital rCBF focally increased, suggesting that functional visual association cortex deficits may cause visual hallucinations in patients with DLB.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16567718     DOI: 10.1212/01.wnl.0000203114.03976.b0

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  26 in total

1.  Association cortex hypoperfusion in mild dementia with Lewy bodies: a potential indicator of cholinergic dysfunction?

Authors:  Tamara G Fong; Sharon K Inouye; Weiying Dai; Daniel Z Press; David C Alsop
Journal:  Brain Imaging Behav       Date:  2011-03       Impact factor: 3.978

Review 2.  Visual spatial cognition in neurodegenerative disease.

Authors:  Katherine L Possin
Journal:  Neurocase       Date:  2010-06-02       Impact factor: 0.881

3.  Advances in the treatment of visual hallucinations in neurodegenerative diseases.

Authors:  Daniel Collerton; John-Paul Taylor
Journal:  Future Neurol       Date:  2013-07

4.  Multimodality imaging characteristics of dementia with Lewy bodies.

Authors:  Kejal Kantarci; Val J Lowe; Bradley F Boeve; Stephen D Weigand; Matthew L Senjem; Scott A Przybelski; Dennis W Dickson; Joseph E Parisi; David S Knopman; Glenn E Smith; Tanis J Ferman; Ronald C Petersen; Clifford R Jack
Journal:  Neurobiol Aging       Date:  2011-10-21       Impact factor: 4.673

5.  Clinical Reasoning: a 75-year-old man with 3 years of visual difficulties.

Authors:  Aaron L Berkowitz; Matthew F Rose; Kirk R Daffner; Sashank Prasad
Journal:  Neurology       Date:  2014-10-21       Impact factor: 9.910

6.  Imaging and acetylcholinesterase inhibitor response in dementia with Lewy bodies.

Authors:  Jonathan Graff-Radford; Bradley F Boeve; Otto Pedraza; Tanis J Ferman; Scott Przybelski; Timothy G Lesnick; Prashanthi Vemuri; Matthew L Senjem; Glenn E Smith; David S Knopman; Val Lowe; Clifford R Jack; Ronald C Petersen; Kejal Kantarci
Journal:  Brain       Date:  2012-07-18       Impact factor: 13.501

7.  A standardized [18F]-FDG-PET template for spatial normalization in statistical parametric mapping of dementia.

Authors:  Pasquale Anthony Della Rosa; Chiara Cerami; Francesca Gallivanone; Annapaola Prestia; Anna Caroli; Isabella Castiglioni; Maria Carla Gilardi; Giovanni Frisoni; Karl Friston; John Ashburner; Daniela Perani
Journal:  Neuroinformatics       Date:  2014-10

8.  Focal atrophy in dementia with Lewy bodies on MRI: a distinct pattern from Alzheimer's disease.

Authors:  Jennifer L Whitwell; Stephen D Weigand; Maria M Shiung; Bradley F Boeve; Tanis J Ferman; Glenn E Smith; David S Knopman; Ronald C Petersen; Eduardo E Benarroch; Keith A Josephs; Clifford R Jack
Journal:  Brain       Date:  2007-01-31       Impact factor: 13.501

9.  Efficacy and safety of galantamine (reminyl) for dementia in patients with Parkinson's disease (an open controlled trial).

Authors:  I V Litvinenko; M M Odinak; V I Mogil'naya; A Yu Emelin
Journal:  Neurosci Behav Physiol       Date:  2008-11

10.  Duration and Pathologic Correlates of Lewy Body Disease.

Authors:  Jonathan Graff-Radford; Jeremiah Aakre; Rodolfo Savica; Bradley Boeve; Walter K Kremers; Tanis J Ferman; David T Jones; Kejal Kantarci; David S Knopman; Dennis W Dickson; Walter A Kukull; Ronald C Petersen
Journal:  JAMA Neurol       Date:  2017-03-01       Impact factor: 18.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.